{"id":"W2983230949","doi":"10.1182/blood-2019-124552","title":"Efficacy and Safety of CPX-351 Versus 7+3 in a Phase 3 Exploratory Analysis in Patients with High-Risk/Secondary Acute Myeloid Leukemia (AML) with Prior Hypomethylating Agent Exposure Who Achieved Remission","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Hypomethylating agent; Medicine; Azacitidine; Myeloid leukemia; Oncology; Internal medicine; Decitabine; Leukemia; Phases of clinical research; Clinical trial; Biology; DNA methylation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002331786,0.001221194,0.001769498,0.0004013871,0.0003636426,0.00113371,0.0006713265,0.0008256324,0.003125924],"category_scores_gemma":[0.001020772,0.000417247,0.002686033,0.0004252464,0.0009197575,0.001012752,0.0005078681,0.002995051,0.0005536431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001177429,"about_ca_system_score_gemma":0.001233536,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006488137,"about_ca_topic_score_gemma":0.001905669,"domain_scores_codex":[0.9993213,0.0003512592,0.00002911626,0.0001319833,0.00005568721,0.0001107518],"domain_scores_gemma":[0.9991855,0.0001483901,0.0001931506,0.00007605187,0.00003948609,0.000357349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.86804,0.02992441,0.01192645,0.0004866692,0.002398666,0.0001545525,0.0002625016,0.002893153,0.02268467,0.0002416615,0.001576555,0.05941083],"study_design_scores_gemma":[0.3021583,0.655844,0.03162949,0.00004138269,0.001656859,0.0003300026,0.000102134,0.002536429,0.003555844,0.0003375829,0.001762921,0.00004502303],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968951,0.001103355,0.0002627012,0.0001783626,0.00003266316,0.0005539614,0.0004139808,0.00003313788,0.0005266811],"genre_scores_gemma":[0.9961101,0.0007479458,0.0006416035,0.0002675988,0.00005936348,0.0005270826,0.0009854932,0.00001406298,0.000646802],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003125924,"threshold_uncertainty_score":0.01233178,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01002783722548017,"score_gpt":0.2565633593527956,"score_spread":0.2465355221273154,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}